WebbTonix Pharmaceuticals Holding Corp. analyst estimates, including TNXP earnings per share estimates and analyst recommendations. Webb14 apr. 2024 · Data indicates that the EPS growth is expected to be 393.80% in 2024, while the next year’s EPS growth is forecast to be 46.10%. Analysts have estimated the company’s revenue for the quarter at $871.47 million, with a low estimate of $826.82 million and a high estimate of $906.59 million.

Tonix Pharmaceuticals Stock Price Forecast. Should You Buy TNXP?

Webb(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's 52-week high was $7.49, and its 52-week low was $0.29. It is currently -92.11% from its 52-week high and 104.5% from its 52 … Webb14 apr. 2024 · Analysts are projecting the company’s earnings per share (EPS) to be -$0.47, which is expected to increase to $0.01 for fiscal year -$3 and then to about -$0.84 by fiscal year 2024. Data indicates that the EPS growth is expected to be 65.70% in 2024, while the next year’s EPS growth is forecast to be 72.00%. portmanteau leather

TNXP - Stock Quotes for Tonix Pharmaceut - Webull

Webb6 apr. 2024 · As of April 6, 2024, TNXP stock price was flat at $0.59 with 276,957 million shares trading. What is Tonix Pharmaceuticals Holding Corp.'s Beta? TNXP has a beta of … WebbTNXP 8 Month Detailed Chart 100% Quote & Volume Scale +/-0 (min) to 10 (max) QUOTE 0.56, -0.02 pts ( -3.5% ), Mon 27 Mar, close -3 down from yesterday's close. Today's L … WebbTNXP Chart Heute −2.80% Woche −2.18% 1 Monat −12.55% 6 Monate 14.70% Seit Jahresbeginn 46.04% 1 Jahr −92.09% 5 Jahre −99.99% Allzeit −100.00% Schlüssel-Statistiken Marktkapitalisierung 35.648M USD Dividendenrendite (GJ) — Kurs-Gewinn-Verhältnis (KGV) — Gewinn je Aktie (TTM) −4.0882 USD Über Tonix Pharmaceuticals … options for alzheimer\u0027s care